SCNI

Scinai Immunotherapeutics

0.8650 USD
-0.0442
4.86%
At close Updated Jan 16, 4:00 PM EST
Pre-market
After hours
0.8700
+0.0050
0.58%
1 day
-4.86%
5 days
6.13%
1 month
2.99%
3 months
-40.75%
6 months
-59.95%
Year to date
18.57%
1 year
-75.77%
5 years
-99.8%
10 years
-99.77%
 

About: Scinai Immunotherapeutics Ltd is a biopharmaceutical company with two complementary business units, one focused on in-house development of inflammation and immunology (I&I) biological therapeutic products beginning with a pipeline of nanosized VHH antibodies (NanoAbs) targeting diseases with large unmet medical needs, and the other a boutique CDMO providing services to help biotech companies efficiently bring their products to market by leveraging Scinai's drug development and GMP and non-GMP manufacturing capabilities for pre-clinical and clinical studies. The company generates maximum revenue from the provision of CDMO (Contract Development and Manufacturing Organization) services.

Employees: 31

0
Funds holding %
of 7,539 funds
Analysts bullish %
Positive news %
Price charts implemented using Lightweight Charts™